{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:44:03Z","timestamp":1785887043955,"version":"3.56.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-4174\/F1"],"award-info":[{"award-number":["IIRP-2023-4174\/F1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/12(39)\/2019"],"award-info":[{"award-number":["ISRM\/12(39)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2019\/003546"],"award-info":[{"award-number":["CRG\/2019\/003546"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["ORF-2025-379"],"award-info":[{"award-number":["ORF-2025-379"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148716","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:00:36Z","timestamp":1762416036000},"page":"148716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Evaluation of immune response in BALB\/c mice generated by SARS-CoV-2 membrane-envelope virus-like particles"],"prefix":"10.1016","volume":"333","author":[{"given":"Akash","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oinam Ningthemmani","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Surjit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam P.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kishore","family":"Inampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148716_bb0005","series-title":"Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews Microbiology 2020 19:3","first-page":"155","volume":"19","author":"V\u2019kovski","year":"2020"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148716_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations, and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0015","unstructured":"SARS-CoV-2 variants of concern as of 27 September 2024 n.d. https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern (accessed November 3, 2024)."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0020","first-page":"124","article-title":"Change in binding affinity with ACE2 receptor in beta, delta and omicron SARS CoV2 variants","volume":"14","author":"Mungmunpuntipantip","year":"2022","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0025","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid protein a multifunctional","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0030","series-title":"SARS-CoV-2 Nucleocapsid Protein Forms Condensates with Viral Genomic RNA in","author":"Jack","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/v16111648","article-title":"SARS-CoV-2 assembly: gaining infectivity and beyond","volume":"16","author":"Katiyar","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78656-w","article-title":"Minimal system for assembly of SARS-CoV-2 virus like particles","volume":"10","author":"Swann","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0055","article-title":"Structure of SARS-CoV-2 membrane protein essential for virus assembly","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fbioe.2020.00862","article-title":"Construction of SARS-CoV-2 virus-like particles by mammalian expression system","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0065","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles","volume":"82","author":"Siu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114242","article-title":"SARS-CoV-2 E protein: pathogenesis and potential therapeutic development","volume":"159","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"309","key":"10.1016\/j.ijbiomac.2025.148716_bb0080","first-page":"1864","article-title":"Structural biology: structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"2005","author":"Li","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0085","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1473-3099(21)00262-0","article-title":"SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity","volume":"21","author":"Ramanathan","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0095","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114367","article-title":"Paxlovid (Nirmatrelvir\/ritonavir): a new approach to Covid-19 therapy?","volume":"162","author":"Hashemian","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0105","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0110","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"368","key":"10.1016\/j.ijbiomac.2025.148716_bb0115","first-page":"1331","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"2020","author":"Dai","year":"1979","journal-title":"Science"},{"issue":"374","key":"10.1016\/j.ijbiomac.2025.148716_bb0120","first-page":"1586","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"2021","author":"Owen","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107923","article-title":"Corticosteroid prednisolone and flavonoid Chrysin as drug candidates against SARS-CoV-2 replication: computational and experimental findings","volume":"207","author":"Kumar","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0130","doi-asserted-by":"crossref","first-page":"eabn3041","DOI":"10.1126\/scitranslmed.abn3041","article-title":"The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination","volume":"14","author":"Benschop","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(22)00163-5","article-title":"Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","author":"Abani","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0140","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S2666-5247(21)00358-X","article-title":"Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults","volume":"3","author":"Ahn","year":"2022","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0145","first-page":"31","article-title":"Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of an open-label, phase 1 clinical trial","author":"Tebas","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0155","first-page":"19","article-title":"Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12\u201317 years: a systematic review and meta-analysis","author":"Katoto","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0160","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1016\/j.vaccine.2023.09.013","article-title":"An overview of protein-based SARS-CoV-2 vaccines","volume":"41","author":"Suryawanshi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0165","article-title":"Coronavirus spike protein-based vaccines","volume":"24","author":"Asrorov","year":"2024","journal-title":"Vaccine delivery systems. Med. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","article-title":"A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity","volume":"601","author":"Heitmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2023.11.009","article-title":"Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults","volume":"139","author":"Tandler","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0180","first-page":"9","article-title":"Efficacy and safety of covid-19 vaccines: a systematic review and meta-analysis of randomized clinical trials","author":"Pormohammad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0185","first-page":"9","article-title":"Efficacy and safety of covid-19 vaccines in phase iii trials: a meta-analysis","author":"Cheng","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0190","doi-asserted-by":"crossref","unstructured":"Higdon MM, Wahl B, Jones CB, Rosen JG, Truelove SA, Baidya A, et al. A Systematic Review of Coronavirus Disease 2019 Vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease. Open Forum Infect. Dis. 2022;9. doi: https:\/\/doi.org\/10.1093\/OFID\/OFAC138.","DOI":"10.1093\/ofid\/ofac138"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0195","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2666-5247(22)00390-1","article-title":"Efficacy of SARS-CoV-2 vaccines and the dose\u2013response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials","volume":"4","author":"Yang","year":"2023","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0200","doi-asserted-by":"crossref","first-page":"27311","DOI":"10.1038\/s41598-024-79122-7","article-title":"Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection","volume":"14","author":"Chulanetra","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0205","first-page":"12","article-title":"Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam","author":"Nguyen","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/prot.22570","article-title":"Improving physical realism, stereochemistry and side-chain accuracy in homology modeling: four approaches that performed well in CASP8","volume":"77","author":"Krieger","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0220","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0225","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0230","first-page":"38","article-title":"Methotrexate, an anti-inflammatory drug, inhibits hepatitis E viral replication","author":"Kumar","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0235","series-title":"Comparing Solvent Models for Molecular Dynamics of Protein","author":"Mashayak","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0240","first-page":"9","article-title":"Hepatitis E virus cysteine protease has papain like properties validated by in silico modeling and cell-free inhibition assays","author":"Saraswat","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0245","doi-asserted-by":"crossref","first-page":"1570108","DOI":"10.3389\/fphar.2025.1570108","article-title":"Ethyl acetate extract of Ruta graveolens: a specific and potent inhibitor against the drug-resistant EGFR_T790M mutant in NSCLC","volume":"16","author":"Kumar","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113498","article-title":"Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2","volume":"28","author":"Singh","year":"2025","journal-title":"IScience"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-323-44329-6.00001-2","article-title":"Mechanisms of disease and immunity","author":"Mealey","year":"2018","journal-title":"Equine Internal Medicine: Fourth Edition"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.it.2007.02.001","article-title":"Gut lymphocyte migration: we are halfway \u201chome.\u201d","volume":"28","author":"McGhee","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155637","article-title":"Between immunomodulation and immunotolerance: the role of IFN\u03b3 in SARS-CoV-2 disease","volume":"146","author":"Todorovi\u0107-Rakovi\u0107","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza a (H1N1) virus: from cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01100","article-title":"Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs","volume":"11","author":"Zepeda-Cervantes","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0280","series-title":"Regulation of the Immune Response by TGF-\u03b2: From Conception to Autoimmunity and Infection","first-page":"9","author":"Sanjabi","year":"2017"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0285","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2007.02719.x","article-title":"Immunological decision-making: how does the immune system decide to mount a helper T-cell response?","volume":"123","author":"Kaiko","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0290","doi-asserted-by":"crossref","first-page":"6917185","DOI":"10.1155\/2020\/6917185","article-title":"The role of Th17 cells and IL-17 in Th2 immune responses of allergic conjunctivitis","volume":"2020","author":"Meng","year":"2020","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0295","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12982-024-00140-x","article-title":"Evolution and implications of SARS-CoV-2 variants in the post-pandemic era","volume":"21","author":"Manirambona","year":"2024","journal-title":"Discover Public Health"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0305","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1128\/JVI.72.11.8636-8643.1998","article-title":"Coronavirus Pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes","volume":"72","author":"Baudoux","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0310","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/j.1460-2075.1996.tb00553.x","article-title":"Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes","volume":"15","author":"Vennema","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0315","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1128\/JVI.72.8.6838-6850.1998","article-title":"Coronavirus particle assembly: primary structure requirements of the membrane protein","volume":"72","author":"de Haan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/vaccines12060561","article-title":"Rapid and scalable production of functional SARS-CoV-2 virus-like particles (VLPs) by a stable HEK293 cell Pool","volume":"12","author":"Puarattana-aroonkorn","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0325","article-title":"Virus-like particles (VLPs)-based vaccines against COVID-19: where do we stand amid the ongoing evolution of SARS-CoV-2?","volume":"9","author":"Dhawan","year":"2023","journal-title":"Health Sci. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0330","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1128\/jvi.71.12.9427-9433.1997","article-title":"The function of the spike protein of the mouse hepatitis virus strain A59 can be studied using virus-like particles; cleavage is not required for infectivity","volume":"71","author":"Bos","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0335","doi-asserted-by":"crossref","first-page":"27311","DOI":"10.1038\/s41598-024-79122-7","article-title":"Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection","volume":"14","author":"Chulanetra","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0340","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/v14102087","article-title":"Baculovirus-free SARS-CoV-2 virus-like particle production in insect cells for rapid neutralization assessment","volume":"14","author":"Jaron","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0345","first-page":"12","article-title":"Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam","author":"Nguyen","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0350","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/v14050914","article-title":"SARS-CoV-2 virus-like particles produced by a single recombinant Baculovirus generate anti-S antibody and protect against variant challenge","volume":"14","author":"Sullivan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0355","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/vaccines9060554","article-title":"Production of SARS-CoV-2 virus-like particles in insect cells","volume":"9","author":"Mi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0360","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1099\/0022-1317-76-9-2349","article-title":"Human enteric Caliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus","volume":"76","author":"Dingle","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0365","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1128\/jvi.65.5.2702-2706.1991","article-title":"Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins","volume":"65","author":"Brown","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0370","first-page":"19","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0375","article-title":"Virus-like particles (VLPs)-based vaccines against COVID-19: where do we stand amid the ongoing evolution of SARS-CoV-2?","volume":"9","author":"Dhawan","year":"2023","journal-title":"Health Sci. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0380","first-page":"3","article-title":"Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells","author":"Bai","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0385","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/156652407780059140","article-title":"Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines","volume":"7","author":"Jennings","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0390","doi-asserted-by":"crossref","unstructured":"Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics, and molecular patterns. Nat. Rev. Immunol. 2010 10:11 2010;10:787\u201396. doi: https:\/\/doi.org\/10.1038\/nri2868.","DOI":"10.1038\/nri2868"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-76163-w","article-title":"A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective","volume":"14","author":"Vuitika","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0400","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1016\/j.vaccine.2022.05.087","article-title":"Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity","volume":"40","author":"Shanmugaraj","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0405","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/14760584.2024.2337051","article-title":"Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study","volume":"23","author":"Tang","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0410","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Efficacy and safety of a recombinant plant-based Adjuvanted Covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41392-022-01041-8","article-title":"Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 omicron variant","volume":"7","author":"Tai","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148716_bb0420","doi-asserted-by":"crossref","first-page":"1560330","DOI":"10.3389\/fcimb.2025.1560330","article-title":"Self-assembled epitope-based nanoparticles targeting the SARS-CoV-2 spike protein enhanced the immune response and induced potential broad neutralizing activity","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025092736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025092736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:09:39Z","timestamp":1766077779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025092736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":84,"alternative-id":["S0141813025092736"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148716","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immune response in BALB\/c mice generated by SARS-CoV-2 membrane-envelope virus-like particles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148716"}}